Sophia Frentzas

Vessel co-option mediates resistance to anti-angiogenic therapy in liver metastases

Sophia Frentzas, Ève Simoneau, Victoria L. Bridgeman et al. · Nature Medicine · 2016 · 436 citations

Medicine, Cancer Biology, Oncology +16

Durvalumab Plus Carboplatin/Paclitaxel Followed by Maintenance Durvalumab With or Without Olaparib as First-Line Treatment for Advanced Endometrial Cancer: The Phase III DUO-E Trial

Shannon N. Westin, Kathleen N. Moore, Hye Sook Chon et al. · Journal of Clinical Oncology · 2023 · 331 citations · Full text

Medicine, Oncology, Pharmacology +12

International consensus guidelines for scoring the histopathological growth patterns of liver metastasis

Pieter‐Jan van Dam, Eric P. van der Stok, Laure-Anne Teuwen et al. · British Journal of Cancer · 2017 · 232 citations · Full text

Medicine, Oncology, Pathology +17

Vessel co‐option is common in human lung metastases and mediates resistance to anti‐angiogenic therapy in preclinical lung metastasis models

Victoria L. Bridgeman, Peter Vermeulen, Shane Foo et al. · The Journal of Pathology · 2016 · 209 citations · Full text

Medicine, Cancer Biology, Oncology +17

A gut microbial signature for combination immune checkpoint blockade across cancer types

Ashray Gunjur, Yan Shao, Timothy Rozday et al. · Nature Medicine · 2024 · 127 citations · Full text

Life Sciences, Microbiology, Oncology +17